← Open Payments lookup

CHEYANNE WILLIAMSON: Open Payments

NPI 1487176236 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$900 in 53 payments from 16 companies in 2025. Trend: 2023 $260 · 2024 $265 · 2025 $900

Food & beverage: $900
CompanyPaymentsAmount
PFIZER INC.12$179
ABBVIE INC.13$175
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$81
Abbott Laboratories2$76
AstraZeneca Pharmaceuticals LP4$64
Otsuka America Pharmaceutical, Inc.2$56
Lilly USA, LLC3$54
GlaxoSmithKline, LLC.3$45
CSL Behring1$35
Novo Nordisk Inc2$34

Products named: VRAYLAR, CAPLYTA, FREESTYLE LIBRE 3, PREVNAR 20, REXULTI, UBRELVY, ELIQUIS, AIRSUPRA.

Industry payments across KS — which companies pay providers there.